- 5 Risultati
prezzo più basso: € 234,25, prezzo più alto: € 371,59, prezzo medio: € 304,49
1
Pharmacotherapy of Pulmonary Hypertension
Ordina
da Orellfuessli.ch
CHF 385,90
(indicativi € 371,59)
Spedizione: € 17,331
Ordina
Dettagli del offerente
Link sponsorizzato

Pharmacotherapy of Pulmonary Hypertension - nuovo libro

ISBN: 9783642386640

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this … Altro …

Nr. A1033198194. Costi di spedizione:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Sofort per Download lieferbar, zzgl. Versandkosten. (EUR 17.33)
Chiudere (X)
2
Pharmacotherapy of Pulmonary Hypertension - Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch
Ordina
da Springer.com
CHF 255,73
(indicativi € 234,25)
Ordina
Dettagli & spedizione
Link sponsorizzato

Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch:

Pharmacotherapy of Pulmonary Hypertension - nuovo libro

ISBN: 9783642386640

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this … Altro …

new in stock CH:::0.00 EUR. Costi di spedizione:zzgl. Versandkosten., Costi di spedizione aggiuntivi
Chiudere (X)
3
Pharmacotherapy of Pulmonary Hypertension - Springer
Ordina
da Thalia.de
€ 319,93
Spedizione: € 0,001
Ordina
Dettagli del offerente
Link sponsorizzato
Springer:
Pharmacotherapy of Pulmonary Hypertension - nuovo libro

2013

ISBN: 9783642386640

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this … Altro …

Nr. 38576208. Costi di spedizione:, Sofort per Download lieferbar, DE. (EUR 0.00)
Chiudere (X)
4
Pharmacotherapy of Pulmonary Hypertension - Shonali Sabherwal
Ordina
da hive.co.uk
£ 233,33
(indicativi € 276,74)
Ordina
Dettagli & spedizione
Link sponsorizzato
Shonali Sabherwal:
Pharmacotherapy of Pulmonary Hypertension - nuovo libro

ISBN: 9783642386640

This book focuses on current, evidence-based pharmacological treatments of various forms of pulmonary hypertension and also provides a comprehensive review of recent developments in this … Altro …

No. 9783642386640. Costi di spedizione:Instock, Despatched same working day before 3pm, zzgl. Versandkosten., Costi di spedizione aggiuntivi
Chiudere (X)
5
Pharmacotherapy of Pulmonary Hypertension - Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch
Ordina
da lehmanns.de
€ 319,93
Spedizione: € 0,001
Ordina
Dettagli del offerente
Link sponsorizzato
Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch:
Pharmacotherapy of Pulmonary Hypertension - nuovo libro

2013, ISBN: 9783642386640

eBooks, eBook Download (PDF), 2013, [PU: Springer Berlin], Springer Berlin, 2013

Costi di spedizione:Download sofort lieferbar. (EUR 0.00)
Chiudere (X)
1Poiché alcune piattaforme non trasmettono le condizioni di spedizione e queste possono dipendere dal paese di consegna, dal prezzo di acquisto, dal peso e dalle dimensioni dell'articolo, dall'eventuale iscrizione alla piattaforma, dalla consegna diretta da parte della piattaforma o tramite un fornitore terzo (Marketplace), ecc. è possibile che le spese di spedizione indicate da eurolibro non corrispondano a quelle della piattaforma offerente.

Dati bibliografici del miglior libro corrispondente

Dettagli del libro
Pharmacotherapy of Pulmonary Hypertension
Autore:
Titolo:
ISBN:

9783642386640

Informazioni dettagliate del libro - Pharmacotherapy of Pulmonary Hypertension


EAN (ISBN-13): 9783642386640
ISBN (ISBN-10): 3642386644
Anno di pubblicazione: 2013
Editore: Springer Berlin
576 Pagine
Lingua: eng/Englisch

Libro nella banca dati dal 2012-03-01T01:35:45+01:00 (Zurich)
Pagina di dettaglio ultima modifica in 2022-08-31T08:52:56+02:00 (Zurich)
ISBN/EAN: 9783642386640

ISBN - Stili di scrittura alternativi:
3-642-38664-4, 978-3-642-38664-0
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : johannes peter, humbert, stasch, johann peter, hum, stas peter, staß, marc peter
Titolo del libro: hype, hypertension

Dati dell'editore

Autore: Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch
Titolo: Handbook of Experimental Pharmacology; Pharmacotherapy of Pulmonary Hypertension
Editore: Springer; Springer Berlin
576 Pagine
Anno di pubblicazione: 2013-10-04
Berlin; Heidelberg; DE
Stampato / Fatto in
Lingua: Inglese
Available
IX, 576 p. 66 illus., 56 illus. in color.

EA; E107; eBook; Nonbooks, PBS / Medizin/Pharmazie; Pharmakologie; Verstehen; Vasoactive substances; WHO Group I-V; lung vasculature; pulmonary artery; pulmonary hypertension (PH); pulmonary vein; C; Pharmacology/Toxicology; Pharmaceutical Sciences/Technology; Internal Medicine; Pneumology/Respiratory System; Laboratory Medicine; Molecular Medicine; Pharmacology; Pharmaceutics; Internal Medicine; Pneumology; Biomedical Research; Biomedical and Life Sciences; Medizinische Chemie, Pharmazeutische Chemie; Klinische und Innere Medizin; Lungen- und Bronchialheilkunde; Medizinische Forschung; BB

Over the past decade, major advancements in the understanding of the molecular mechanisms and pathophysiology of pulmonary hypertension occurred in parallel with the discovery and development of new therapies. Pharmacological agents that modulate the main pathophysiological pathways of pulmonary arterial hypertension have changed the course of this devastating disease by relieving symptoms and improving and prolonging patients’ lives.

The first part of the book covers definition, classification, pathophysiology, pathology, biomarkers and animal models of pulmonary hypertension, thus laying the conceptual basis for what follows. The middle section provides an overview of the established therapies, such as calcium channel blockers, prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors and inhaled nitric oxide. The concluding section explores novel pathways and emerging therapeutic approaches including soluble guanylate cyclase stimulators, Rho-kinase inhibitors, inhibitors of serotonin receptors and transporters, peptide growth factors, vasoactive peptides, modulators of redox equilibrium and cyclic nucleotides homeostasis, as well as immunosuppressive and anti-proliferative agents. Particular attention is given to clinical applications of these experimental therapies.

Preface.- Part I. Pulmonary hypertension: conceptual bases of the disease. Pulmonary hypertension: definition, classification, and epidemiology. Pulmonary hypertension: pathophysiology and signalling pathways. Pulmonary hypertension: pathology. Pulmonary hypertension: biomarkers. Pulmonary hypertension: animal models.- Part II. Pulmonary hypertension: established therapies. General supportive care. Calcium channel blockers. Prostacyclins. Endothelin receptor antagonists. Phosphodiesterase 5 inhibitors.- Part III. Pulmonary hypertension: novel pathways and emerging therapies     Soluble guanylate cyclase stimulators. Therapeutics targeting dysregulated redox equilibrium and endothelial dysfunction (NOXs, sGC activators, GSNOR). Rho-kinase inhibitors. Serotonin transporters and serotonin receptors. PDGF inhibitors. Novel anti-proliferative strategies beyond imatinib. Immunosuppressive agents. Vasoactive peptides. Inhibitors of cGMP/cAMP metabolism (MRP4, MRP5, PDE1). Old targets re-visited. Stem cells and cell based therapy.- Part IV. Conclusions and Outlook. Pulmonary hypertension: evidence-based management in the modern era and future directions.

Written by leading experts in the field of pulmonary hypertension

Broadens your understanding of current, evidence-based pharmacological treatments of various forms of pulmonary hypertension

Comprehensive review of most recent developments in this field including new signaling pathways

Includes supplementary material: sn.pub/extras


< Per archiviare...